NO171913C - Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser

Info

Publication number
NO171913C
NO171913C NO893616A NO893616A NO171913C NO 171913 C NO171913 C NO 171913C NO 893616 A NO893616 A NO 893616A NO 893616 A NO893616 A NO 893616A NO 171913 C NO171913 C NO 171913C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
tricyclic compounds
analogy procedure
active tricyclic
Prior art date
Application number
NO893616A
Other languages
English (en)
Norwegian (no)
Other versions
NO893616D0 (no
NO171913B (no
NO893616L (no
Inventor
Yoshinari Sato
Teruaki Matuo
Takatomo Ogahara
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888821257A external-priority patent/GB8821257D0/en
Priority claimed from GB888829265A external-priority patent/GB8829265D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO893616D0 publication Critical patent/NO893616D0/no
Publication of NO893616L publication Critical patent/NO893616L/no
Publication of NO171913B publication Critical patent/NO171913B/no
Publication of NO171913C publication Critical patent/NO171913C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO893616A 1988-09-09 1989-09-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser NO171913C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888821257A GB8821257D0 (en) 1988-09-09 1988-09-09 Tricyclic compounds
GB888829265A GB8829265D0 (en) 1988-12-15 1988-12-15 Tricyclic compounds

Publications (4)

Publication Number Publication Date
NO893616D0 NO893616D0 (no) 1989-09-08
NO893616L NO893616L (no) 1990-03-12
NO171913B NO171913B (no) 1993-02-08
NO171913C true NO171913C (no) 1993-05-19

Family

ID=26294376

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893616A NO171913C (no) 1988-09-09 1989-09-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser

Country Status (18)

Country Link
US (2) US4981847A (de)
EP (1) EP0360079B1 (de)
JP (3) JPH0665673B2 (de)
KR (1) KR900004737A (de)
CN (1) CN1022187C (de)
AU (1) AU628370B2 (de)
DE (1) DE68912858T2 (de)
DK (1) DK444789A (de)
ES (1) ES2061848T3 (de)
FI (1) FI92401C (de)
HK (1) HK101996A (de)
HU (2) HUT54152A (de)
IE (1) IE62916B1 (de)
IL (1) IL91361A (de)
NO (1) NO171913C (de)
PH (1) PH27358A (de)
PT (1) PT91664B (de)
RU (1) RU2007406C1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Benzodiazepinone compounds [4,1] connected via positions 1 and 9 and carrying two transducers, processes for their preparation and pharmaceutical preparations containing them
US5248679A (en) * 1988-09-09 1993-09-28 Fujisawa Pharmaceutical Co., Ltd. Tricyclic compounds
IL93401A (en) * 1989-03-08 1994-08-26 Kali Chemie Pharma Gmbh H1 - Indole - 2 - Carboxylic acid 1, 7 - Consolidated N -) 1, 4 - Benzodiazepine - 3 - Il (amides, their preparation and drugs containing them
FR2652352A1 (fr) * 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
GB9018601D0 (en) * 1990-08-24 1990-10-10 Fujisawa Pharmaceutical Co Tricyclic compounds
CA2056809A1 (en) * 1990-12-07 1992-06-08 Mark G. Bock Benzodiazepine analogs
EP0572235A3 (en) * 1992-05-28 1994-06-01 Tanabe Seiyaku Co Beta-carboline derivatives with anticholecystoquinine activity
GB2271354A (en) * 1992-10-07 1994-04-13 Merck Sharp & Dohme Tricyclic derivatives of benzodiazepines
AU6045994A (en) * 1993-03-03 1994-09-26 Fujisawa Pharmaceutical Co., Ltd. Optical isomerization inhibitor
ATE211464T1 (de) * 1993-11-26 2002-01-15 Tanabe Seiyaku Co 2-oxoindolin-derivate als cholecystokinin rezeptor antagonisten
WO1996004254A2 (en) * 1994-07-29 1996-02-15 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
ZA957201B (en) * 1994-08-30 1996-04-01 Fujisawa Pharmaceutical Co Liposome preparation
FR2725719B1 (fr) * 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv
US5716958A (en) 1994-10-27 1998-02-10 Tobishi Pharmaceutical Co., Ltd. Amino acid derivative having anti-CCK activity
AUPO284396A0 (en) 1996-10-08 1996-10-31 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
FR2776660B1 (fr) * 1998-03-27 2000-05-12 Parke Davis Diazepino-indoles de phosphodiesterases iv
EP2897942B1 (de) 2012-09-21 2016-08-31 Bristol-Myers Squibb Company Fluoralkyl- und fluorocycloalkyl-1,4-benzodiazepinonverbindungen als notch-inhibitoren
CN104797584A (zh) 2012-09-21 2015-07-22 百时美施贵宝公司 作为notch抑制剂的三环杂环化合物
EP2897944B1 (de) 2012-09-21 2016-10-26 Bristol-Myers Squibb Company Substituierte 1,5-benzodiazepinon-verbindungen
EP2897946B1 (de) 2012-09-21 2016-11-16 Bristol-Myers Squibb Company N-substituierte bis(fluoralkyl)-1,4-benzodiazepinonverbindungen
CN104968648A (zh) 2012-09-21 2015-10-07 百时美施贵宝公司 1,4-苯并二氮杂*酮化合物的前药
JP2015534554A (ja) 2012-09-21 2015-12-03 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ アルキル，フルオロアルキル−１，４−ベンゾジアゼピノン化合物
WO2014047392A1 (en) 2012-09-21 2014-03-27 Bristol-Myers Squibb Company Fluoroalkyl-1,4-benzodiazepinone compounds
JP2015529250A (ja) 2012-09-21 2015-10-05 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ フルオロアルキルジベンゾジアゼピノン化合物
US9492469B2 (en) 2013-04-04 2016-11-15 Bristol-Myers Squibb Company Combination therapy for the treatment of proliferative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3651083A (en) * 1969-11-03 1972-03-21 Upjohn Co Tetra- and hexahydro-phenylpyrrolo benzodiazepines and intermediates
AU2733371A (en) * 1970-04-14 1972-10-12 A. H. Robins Company, Incorporated 5, 7-DISUBSTITUTED-l, 9-ALKYLENE-l, 4-BENZODIAZEPIN-2 ONES
US3794646A (en) * 1970-04-14 1974-02-26 Robins Co Inc A H 5,7-disubstituted-1,9-tetramethylene-1,4-benzodiazepin-2-ones
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
US4735941A (en) * 1986-12-23 1988-04-05 Merck & Co., Inc. 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Benzodiazepinone compounds [4,1] connected via positions 1 and 9 and carrying two transducers, processes for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
DE68912858T2 (de) 1994-06-01
DE68912858D1 (de) 1994-03-17
DK444789A (da) 1990-03-10
IE62916B1 (en) 1995-03-08
DK444789D0 (da) 1989-09-08
EP0360079B1 (de) 1994-02-02
IE892840L (en) 1990-03-09
IL91361A0 (en) 1990-03-19
RU2007406C1 (ru) 1994-02-15
NO893616D0 (no) 1989-09-08
PH27358A (en) 1993-06-21
JPH02111774A (ja) 1990-04-24
JPH0665673B2 (ja) 1994-08-24
FI894169A (fi) 1990-03-10
PT91664A (pt) 1990-03-30
IL91361A (en) 1994-10-07
PT91664B (pt) 1995-05-31
AU4025789A (en) 1990-03-15
CN1022187C (zh) 1993-09-22
FI92401C (fi) 1994-11-10
FI894169A0 (fi) 1989-09-05
CN1040981A (zh) 1990-04-04
JPH0748373A (ja) 1995-02-21
NO171913B (no) 1993-02-08
FI92401B (fi) 1994-07-29
HK101996A (en) 1996-06-21
AU628370B2 (en) 1992-09-17
KR900004737A (ko) 1990-04-12
HU211264A9 (en) 1995-11-28
US4981847A (en) 1991-01-01
JPH0741480A (ja) 1995-02-10
NO893616L (no) 1990-03-12
JP2848230B2 (ja) 1999-01-20
ES2061848T3 (es) 1994-12-16
US5155101A (en) 1992-10-13
EP0360079A1 (de) 1990-03-28
HUT54152A (en) 1991-01-28

Similar Documents

Publication Publication Date Title
NO171913C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser
NO172801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO168174C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser
NO171272C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,4-triazolforbindelser
NO895086D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO172581C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske ketoner
NO170727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyran-derivater
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO169438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser
NO884174D0 (no) Framgangsmaate for fremstilling av terapeutisk aktive tricykliske amidinoderivater.
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO172539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO170582C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser
NO173185C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser
NO173061C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO172643C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater
NO172802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner
NO171847C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater
NO168820C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzazepin-derivater
NO162617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske imidazolderivater.
NO172115C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bronkospasmolytiske forbindelser